Despite the large overlap in the 95% CI intervals between the groups, a trend towards and increased M/E ratio was observed in late stage (from IB onwards) and high-grade tumors, as well as in tumors with serous and carcinosarcoma histology and p53 abnormal molecular classification (abnormal p53 expression, high risk). The gene discussed is TP53; the disease is carcinosarcoma.